2.00
0.00 (0.00%)
| Penutupan Terdahulu | 2.00 |
| Buka | 2.01 |
| Jumlah Dagangan | 549,000 |
| Purata Dagangan (3B) | 10,004,887 |
| Modal Pasaran | 4,256,868,608 |
| Harga / Pendapatan (P/E TTM) | 28.57 |
| Harga / Jualan (P/S) | 2.88 |
| Harga / Buku (P/B) | 0.940 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 30 Mar 2026 |
| Margin Keuntungan | 8.42% |
| Margin Operasi (TTM) | 11.23% |
| EPS Cair (TTM) | 0.070 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -0.80% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 11,430.90% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 33.65% |
| Nisbah Semasa (MRQ) | 1.67 |
| Aliran Tunai Operasi (OCF TTM) | 373.99 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 188.26 M |
| Pulangan Atas Aset (ROA TTM) | 1.98% |
| Pulangan Atas Ekuiti (ROE TTM) | 5.92% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | VIVA BIOTECH | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -2.0 |
| Purata | -0.63 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| VIVA BIOTECH | 4 B | - | 28.57 | 0.940 |
| CSTONE PHARMA-B | 14 B | - | - | 27.87 |
| CKLIFE SCIENCES | 7 B | - | - | 1.88 |
| ANTENGENE-B | 3 B | - | - | 2.84 |
| SINOMAB BIO-B | 2 B | - | - | 4.23 |
| IMMUNOTECH-B | 2 B | - | - | 20.15 |
|
Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 43.29% |
| % Dimiliki oleh Institusi | 7.84% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |